WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today previewed its unaudited financial highlights for the fourth quarter ended December 31, 2013 .

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, announced that it had entered into an agreement with Omron Medical Devices, a subsidiary of Omron Healthcare China, to

NeuroMetrix to Present at 7th Annual OneMedForum: Investing in Healthcare 2014 WALTHAM, Mass. --(BUSINESS WIRE)--Dec. 4, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.SENSUS Rx .com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today

NeuroMetrix Launches www.SENSUSRx.com WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 22, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced the launch of www.SENSUS Rx .com .

NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 7, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the treatment and management of the neurological complications of diabetes,

Progress in Building Broad Distribution Channel for SENSUS™ Pain Management System

NeuroMetrix, Inc. Announces Date for 2013 Third Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 16, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2013 third quarter financial results before the opening of the market on October 23, 2013 .

NeuroMetrix Enters into Agreement with Rehabilitation Management Group, Inc. and OsteoArthritis Centers of America to Make SENSUS Pain Management System Available in its Affiliated Clinics WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 15, 2013-- NeuroMetrix, Inc.

NeuroMetrix Appoints David Van Avermaete to Board of Directors WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 1, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today

NeuroMetrix To Exhibit at Medtrade Tradeshow and Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today